cbdMD, Inc.
cbdMD, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 3 | 3 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | - | 1 | 1 | - | - | |||||
Accounts Receivable Gross Current | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | 1 | |||||
Disposal Group Including Discontinued Operation Ac… | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Inventory Gross | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 4 | 4 | |||||
Other Short Term Investments | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | |||||
Assets Current | 8 | 8 | 8 | 7 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | |||||
Other Assets | |||||||||||||||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 3 | 3 | 3 | |||||
Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Goodwill | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Other Long Term Investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 7 | 7 | 8 | 8 | |||||
Assets | 13 | 12 | 12 | 10 | 10 | 11 | 12 | 11 | 14 | 15 | 15 | 16 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | |||||
Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | |||||
Dividends Payable Current | 0 | 0 | - | 0 | 0 | 7 | 6 | 5 | 4 | 3 | - | 1 | |||||
Contract With Customer Liability Current | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | |||||
Convertible Debt Current | - | - | - | - | 0 | 0 | 0 | 1 | - | - | - | 0 | |||||
Notes Payable Current | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 3 | 3 | 3 | 3 | 4 | 10 | 9 | 9 | 8 | 7 | 6 | 5 | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Liabilities | 5 | 3 | 3 | 3 | 4 | 10 | 10 | 9 | 11 | 11 | 8 | 7 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Liabilities Noncurrent | |||||||||||||||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | 1 | 3 | - | - | |||||
Other Liabilities Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | - | - | |||||
Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 1 | 0 | 2 | 2 | 2 | 2 | |||||
Liabilities Noncurrent | - | - | - | 0 | 0 | 0 | 1 | 0 | 3 | 5 | 2 | 2 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 190 | 190 | 189 | 187 | 185 | 185 | 185 | 184 | 184 | 183 | 183 | 183 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | - | 0 | 0 | 0 | -0 | -0 | -0 | -0 | - | 0 | |||||
Retained Earnings Accumulated Deficit | -182 | -181 | -180 | -179 | -179 | -185 | -183 | -182 | -181 | -180 | -176 | -174 | |||||
Stockholders Equity | 8 | 9 | 9 | 7 | 6 | 1 | 2 | 2 | 3 | 3 | 7 | 9 | |||||
Liabilities And Stockholders Equity | 13 | 12 | 12 | 10 | 10 | 11 | 12 | 11 | 14 | 15 | 15 | 16 | |||||
Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | 0 | 0 | - | - | |||||
Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | |||||
Preferred Stock Shares Issued | 2 | 2 | 2 | 2 | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Outstanding | 2 | 2 | 2 | 2 | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Issued | 11 | 10 | 10 | 9 | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Shares Outstanding | 11 | 10 | 10 | 9 | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.51% | -12.37% | 8.25% | -10.62% | -15.43% | -41.85% | - | - | - | - | - | - |
| 2025 | -35.79% | -59.12% | -67.02% | -3.43% | -13.13% | -13.13% | -14.00% | 36.47% | 2.94% | -29.14% | -38.87% | -48.34% |
| 2024 | 5.43% | 28.71% | 23.14% | -6.52% | -20.54% | -17.85% | 17.53% | -2.68% | -5.36% | 41.46% | 33.17% | -8.04% |
| 2023 | - | - | - | - | - | - | - | - | - | 15.62% | 7.88% | 7.74% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.50 | 2.82 | 2.94 | 2.05 | 1.56 | 0.63 | 0.69 | 0.74 | 0.93 | 1.07 | 1.23 | 1.73 | |||||
| Quick Ratio | 1.32 | 1.53 | 1.69 | 1.11 | 0.68 | 0.31 | 0.39 | 0.42 | 0.43 | 0.48 | 0.47 | 0.70 | |||||
| Working Capital | 4.62M | 5.42M | 5.39M | 3.36M | 2.01M | -3.68M | -2.81M | -2.23M | -567.61K | 473.69K | 1.39M | 3.40M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.60 | 0.32 | 0.31 | 0.44 | 0.62 | 15.43 | 5.48 | 4.39 | 3.57 | 3.71 | 1.15 | 0.79 | |||||
| Interest Coverage TTM | -192.45 | -126.15 | -90.66 | -63.03 | -58.78 | -37.55 | -52.38 | -98.65 | -262.73 | -339.87 | -471.36 | -320.86 | |||||
| Debt Ratio | 0.38 | 0.24 | 0.24 | 0.31 | 0.38 | 0.94 | 0.85 | 0.81 | 0.78 | 0.79 | 0.53 | 0.44 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.82 | 1.72 | 1.64 | 1.83 | 1.60 | 1.54 | 1.48 | 1.49 | 0.90 | 0.93 | 0.95 | 0.88 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | - | 15.82 | 14.13 | - | - | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | - | 23.07 | 25.82 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | - | - | - | - | - | - | - | - | -58.50 | - | -90.74 | |||||
| Free Cash Flow Per Share TTM | -0.23 | -0.25 | -0.24 | -0.41 | -0.21 | -0.31 | -1.31 | -1.02 | -2.43 | -4.66 | -7.71 | -19.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.49 | 4.51 | 7.21 | 14.51 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 57.68% | 59.38% | 60.59% | 62.36% | 61.20% | 62.35% | 60.22% | 60.21% | 61.95% | 60.36% | 61.88% | 59.78% | |||||
| Operating Profit Margin TTM | -13.87% | -13.40% | -12.37% | -11.27% | -9.43% | -6.49% | -11.88% | -16.64% | -86.20% | -87.68% | -80.65% | -89.76% | |||||
| Net Profit Margin TTM | -7.80% | -8.68% | -7.01% | -10.63% | -9.71% | -0.81% | -13.68% | -18.57% | -87.18% | -96.57% | -82.59% | -91.56% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 10.02% | 2.00% | -2.88% | -3.67% | -9.96% | -12.61% | -18.72% | -20.48% | -23.81% | -25.62% | -27.81% | -32.51% | |||||
| Net Income Growth (1Y) | -11.59% | 992.87% | -50.21% | -44.84% | -89.97% | -99.27% | -86.54% | -83.87% | -15.09% | -58.00% | -63.59% | -67.27% | |||||
| EPS Growth (1Y) | -51.84% | -18.54% | -96.85% | -92.61% | -99.22% | -99.65% | -91.25% | -92.44% | -43.76% | -80.92% | -83.51% | -78.51% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -4.38 | -4.47 | -9.08 | -2.38 | -2.79 | -9.02 | -0.63 | -0.55 | -0.12 | -0.13 | -0.15 | -0.09 | |||||
| P/B TTM | 0.87 | 0.83 | 1.35 | 0.67 | 0.84 | 2.15 | 0.96 | 1.03 | 0.70 | 0.89 | 0.44 | 0.23 | |||||
| P/S TTM | 0.34 | 0.39 | 0.64 | 0.25 | 0.27 | 0.07 | 0.09 | 0.10 | 0.10 | 0.12 | 0.13 | 0.08 | |||||
| Market Cap | 7.14M | 7.75M | 12.16M | 4.87M | 5.16M | 1.43M | 1.71M | 2.03M | 2.12M | 2.75M | 3.08M | 2.09M | |||||
| Enterprise Value | 5.03M | 5.12M | 8.77M | 2.61M | 4.10M | -332.96K | 98.83K | 745.65K | 1.10M | 3.35M | 1.57M | 297.74K | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -2.41M | -2.65M | -2.13M | -1.64M | -1.24M | -240.16K | -743.87K | -552.05K | -1.09M | -1.73M | -2.85M | -4.80M | |||||
| Net Debt | -2.11M | -2.63M | -3.39M | -2.26M | -1.06M | -1.77M | -1.61M | -1.28M | -1.02M | 596.60K | -1.50M | -1.80M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
cbdMD, Inc. (YCBD) — SEC Financial Statements & Analysis
cbdMD, Inc. (YCBD) is a perfumes, cosmetics & other toilet preparations company, incorporated in NC. cbdMD, Inc. trades on NYSE as: YCBD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), cbdMD, Inc. reported a 10.02% year-over-year revenue growth, a Gross Profit Margin of 57.68% (TTM), a Debt-to-Equity ratio of 0.60x, a Price-to-Sales (P/S) ratio of 0.34x (TTM), a Price-to-Book (P/B) ratio of 0.87x (TTM), at a market cap of $7.14M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 10.02%
- Gross Profit Margin TTM
- 57.68%
- Debt To Equity
- 0.60x
- P/S TTM
- 0.34x
- P/B TTM
- 0.87x
- Market Cap
- $7.14M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is cbdMD, Inc. in?
cbdMD, Inc. (YCBD) operates in the Perfumes, Cosmetics & Other Toilet Preparations industry.
What is YCBD's market cap?
cbdMD, Inc. (YCBD) has a market capitalization of $7.14M as of 2026-06-30.
What exchange does YCBD trade on?
cbdMD, Inc. (YCBD) trades on the NYSE.
Where is cbdMD, Inc. incorporated?
cbdMD, Inc. is incorporated in NC.